A GoFundMe has been launched for a Santa Clarita child diagnosed with a rare genetic disease to help fund a clinical trial that hopes to improve his quality of life.
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium,.